ArticleScientific reports2017

SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer.

Dong-Ming Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.